Rima Izem

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Therapeutic innovation & regulatory science

Pharmacoepidemiology and drug safety

Journal of biopharmaceutical statistics

Statistics in medicine

Harvard University

University of North Carolina at Chapel Hill (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard University

United States

Assistant Professor :: Department of Statistics

Education History

University of North Carolina at Chapel Hill

United States

PHD :: Statistics

Publications

Rima Izem, Emmanuel Zuber, Nadia Daizadeh, Frank Bretz, Oleksandr Sverdlov, Pascal Edrich, Janice Branson, Evgeny Degtyarev, Nikolaos Sfikas, Robert Hemmings
Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework. Therapeutic innovation & regulatory science 58 (3) (2024)
Rima Izem, Emmanuel Zuber, Nadia Daizadeh, Frank Bretz, Oleksandr Sverdlov, Pascal Edrich, Janice Branson, Evgeny Degtyarev, Nikolaos Sfikas, Robert Hemmings
Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework. Therapeutic innovation & regulatory science (2024)
Rima Izem, Emmanuel Zuber, Nadia Daizadeh, Frank Bretz, Oleksandr Sverdlov, Pascal Edrich, Janice Branson, Evgeny Degtyarev, Nikolaos Sfikas, Robert Hemmings
Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework. Therapeutic innovation & regulatory science 58 (3) (2024)
Amarilys Vega, Rongmei Zhang, Hui-Lee Wong, Michael Wernecke, Michael Alexander, Yuhui Feng, An-Chi Lo, Bradley Lufkin, Qin Ryan, Rima Izem, Thomas E MaCurdy, Jeffrey A Kelman, David J Graham
Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle. Pharmacoepidemiology and drug safety 30 (5) (2021)
Rima Izem, Robert McCarter
Randomized and non-randomized designs for causal inference with longitudinal data in rare disorders. Orphanet journal of rare diseases 16 (1) (2021)
Rima Izem, Jiemin Liao, Mao Hu, Yuqin Wei, Sandia Akhtar, Michael Wernecke, Thomas E MaCurdy, Jeffrey Kelman, David J Graham
Comparison of propensity score methods for pre-specified subgroup analysis with survival data. Journal of biopharmaceutical statistics 30 (4) (2020)
Judith C Maro, Efe Eworuke, Laura Hou, Emily C Welch, Margie R Goulding, Rima Izem, Joo-Yeon Lee, Sengwee Toh, Bruce H Fireman, Michael D Nguyen
Conducting prospective sequential surveillance in real-world dynamic distributed databases. Pharmacoepidemiology and drug safety 29 (10) (2020)
Rima Izem, Ting-Ying Huang, Laura Hou, Ella Pestine, Michael Nguyen, Judith C Maro
Quantifying how small variations in design elements affect risk in an incident cohort study in claims. Pharmacoepidemiology and drug safety 29 (1) (2019)
Sai Dharmarajan, Joo-Yeon Lee, Rima Izem
Sample size estimation for case-crossover studies. Statistics in medicine 38 (6) (2018)

Rima Izem.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rima Izem